Baylor Scott & White Medical Centers in Temple and Round Rock have opened enrollment on a study examining the safety and efficacy of Etripamil Nasal Spray in terminating paroxysmal supraventricular tachycardia (PSVT). These locations represent two of just four sites across the entire state of Texas that were awarded the trial.